Abstract:
Coating compositions comprising at least one hydroxyl-containing compound (A), at least one isocyanato-containing compound (B) and at least one urea-group-containing compound (H) different from (B), compound (H) comprising at least one structural unit selected from the group consisting of a structural unit (I) a structural unit (II) a structural unit (III) —NR′″—C(O)—N(X—SiR″x(OR′)3-x)n(X′—SiR″y(OR′)3-y)m, and combinations of two or more of the foregoing, compound (H) being obtained by reacting an isocyanato-containing compound (HG) with amino-containing compounds, wherein in compound (H) more than 90 mol % of the isocyanate groups originally present in (HG) have undergone reaction to form the structural units (I), (II), (III), or combinations thereof, where R′, R′″=hydrogen, alkyl, cycloalkyl, aryl or aralkyl; R, R″=alkyl, cycloalkyl, aryl or aralkyl; X, X′=linear and/or branched alkyl or cycloalkyl radical; x, y, n, m=0 to 2; and m+n=2.
Abstract translation:包含至少一种含羟基的化合物(A),至少一种含异氰酸酯基的化合物(B)和至少一种不同于(B)的含脲基化合物(H),化合物(H) 选自结构单元(I),结构单元(II),结构单元(III)-NR'-C(O)-N(X-SiR“x(OR')3 - )的结构单元 x)n(X'-SiR“y(OR')3-y)m和上述两种或更多种的组合,化合物(H)是通过含异氰酸酯基的化合物(HG)与含氨基的化合物 化合物,其中在(HG)中原子存在的大于90摩尔%的异氰酸酯基团的化合物(H)中已经发生反应以形成结构单元(I),(II),(III)或其组合,其中R' R'“=氢,烷基,环烷基,芳基或芳烷基; R,R“=烷基,环烷基,芳基或芳烷基; X,X'=直链和/或支链烷基或环烷基; x,y,n,m = 0〜2; m + n = 2。
Abstract:
A method of preparing a fiber including electro-spinning onto a substrate polymer solutions from a plurality of jets to form a network of filaments, wherein at least one jet sprays onto the substrate a first chemical mixture including a carbon fiber precursor compound, and at least one other jet sprays onto the substrate a second chemical mixture comprising a sacrificial polymer and a precursor compound of a functional material; and processing the filaments on the substrate, thereby forming an arrangement of carbon fibers having the functional material deposited thereon.
Abstract:
A waterborne base coat having a special-effect color and which contains aqueous microgel as binder, 0.5 to 2 wt.-% of poly(meth)acrylic acid thickener and 2 to 7 wt.-% of non-ionically emulsified EVA copolymer wax with a drop point of the wax portion of 80 to 110° C., the wt.-% in each case calculated as solids and relative to the solids content of the waterborne base coat.
Abstract:
A nanoparticle coated hydrogel may be formed by a method of electrospraying nanoparticles on to a surface includes providing a drug and polymer combination in solvent to an inner capillary of a coaxial dual capillary spray nozzle. A coating with a drug that releases over time may be provided. Open and closed matrixes may be selectively formed to help modify time release periods.
Abstract:
A nanoparticle coated hydrogel may be formed by a method of electrospraying nanoparticles on to a hydrogel surface includes providing a drug and polymer combination in solvent to an inner capillary of a coaxial capillary spray nozzle. A coating with a drug that releases over time may be provided. Open and closed matrixes may be selectively formed to help modify time release periods.
Abstract:
A substrate processing apparatus includes a tray, a mask and a rotary stage. The tray includes a substrate support configured to support an outer edge portion of a substrate, a mask support provided on an outer periphery side of the substrate support and projected above the substrate support, and a recess provided between the substrate support and the mask support. The mask covers the recess and the substrate support of the tray. The rotary stage includes an electrostatic adsorption surface and a tray mounting portion provided on an outer periphery side of the electrostatic adsorption surface and below the electrostatic adsorption surface. The outer edge portion of the substrate is projected toward the tray mounting portion side from the electrostatic adsorption surface. The substrate support is spaced below the outer edge portion of the substrate. The mask is spaced above the outer edge portion of the substrate.
Abstract:
Provided is an electrostatic coating method using a conductor such as a metal or a conductive resin as a coating target surface 21, the method including coating the coating target surface 21 with a charged paint by ejecting the charged paint from a spray gun 1 in a state where generation of an electrostatic field between a spray gun 1 and the coating target surface 21 is prevented and generation of free ions is prevented.
Abstract:
A method of applying particles to a backing having a make layer on one of the backing's opposed major surfaces. The method including the steps of: supporting the particles on a feeding member having a feeding surface such that the particles settle into one or more layers on the feeding surface; the feeding surface and the backing being arranged in a non-parallel manner; and translating the particles from the feeding surface to the backing and attaching the particles to the make layer by an electrostatic force.
Abstract:
A process for producing a corrugated electrode for use in an electroactive polymer cartridge is disclosed. A laminated web comprising a support sheet laminated to a dielectric elastomer film is positioned. The support sheet defines areas exposing portions of the dielectric elastomer film. A force is applied to the positioned laminated web to stretch the laminated support sheet-dielectric elastomer film web in a direction that is orthogonal to a plane defined by the web. An electrically conductive material is applied to the laminated support sheet-dielectric elastomer film web while the laminated support sheet-dielectric elastomer film web is in a stretched state. The laminated support sheet-dielectric elastomer film web is relaxed to form the corrugated electrode on the dielectric elastomer film portion of the web.
Abstract:
A system and method are disclosed for coating surfaces of expandable medical devices with composite coatings. Coatings are composed of various materials including, e.g., polymers and drugs. Transfer of the coatings within a patient or other host forms a drug-eluting coating that delivers time-released drugs over time for treatment of a medical condition.